Kaliumklorid Orifarm

Potassium chloride, the active ingredient in Kaliumklorid Orifarm, is a potassium supplement presented as an oral formulation for oral use. It is employed to correct low blood potassium levels and to support normal cellular function in patients with hypokalemia or other potassium deficiencies.

GNH USA supplies Kaliumklorid Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved products to a global network of healthcare providers across multiple regions.

Kaliumklorid Orifarm is used to replace potassium in conditions where serum potassium is low.

- Hypokalemia: restores normal serum potassium levels and helps prevent cardiac complications. - Potassium deficiency due to diuretic therapy: replenishes potassium lost through increased urinary excretion. - Chronic kidney disease with low potassium: assists in maintaining electrolyte balance under medical supervision.

Oral potassium chloride can cause a range of adverse reactions, most of which are related to gastrointestinal irritation or electrolyte disturbances.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools occurring after dosing.

Serious or Rare Side Effects: - Hyperkalemia: dangerously high serum potassium that can cause cardiac arrhythmias. - Severe abdominal pain: may indicate ulceration or perforation of the gastrointestinal tract. - Allergic reaction: rash, itching, or swelling of the face and throat.

When prescribing Kaliumklorid Orifarm, several precautions should be observed to ensure safe use.

- Renal function assessment: evaluate kidney performance before initiating therapy. - Serum potassium monitoring: check levels regularly to avoid hyperkalemia. - Concomitant medications: review use of ACE inhibitors, ARBs, or potassium‑sparing diuretics. - Gastrointestinal disorders: use with caution in patients with peptic ulcer disease. - Cardiac history: monitor ECG in patients with known arrhythmias. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture.

Potassium chloride may interact with several drugs, altering potassium balance or affecting absorption.

Major Interactions (Avoid): - ACE inhibitors or ARBs: combined use can cause significant hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of excess potassium. - NSAIDs: may reduce renal potassium excretion, raising serum levels.

Moderate Interactions (Monitor Closely): - Digoxin: high potassium can diminish digoxin toxicity but requires monitoring. - Beta‑blockers: may mask symptoms of hyperkalemia. - Laxatives containing sodium polystyrene: can bind potassium and reduce effectiveness.